To include your compound in the COVID-19 Resource Center, submit it here.

FDA proposes IND data disclosure

The FDA on Wednesday released a proposed rule on the public disclosure of data about gene therapy and xenotransplantation research that would alter the agency's policy of releasing virtually

Read the full 294 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE